Skip to main content
Fig. 2 | Journal of Experimental & Clinical Cancer Research

Fig. 2

From: p53 mutant-type in human prostate cancer cells determines the sensitivity to phenethyl isothiocyanate induced growth inhibition

Fig. 2

PEITC reactivates p53R175H mutant in LAPC-4 xenograft tumor and inhibits its growth. a Representative images of LAPC-4 prostate xenograft tumors in control (Left Panel) and PEITC-treated (Right Panel) animal groups. b Tumors volumes in animals. (**p ≤ 0.009 and *p ≤ 0.02) (n = 6). c Animal weights (g) were measured weekly. d qRT-PCR (n = 5) of p53 regulated genes in PEITC and control animal groups. (***p ≤ 0.0000)

Back to article page